Abstract
Fracture is one of the most life-threatening injuries in horses. Fracture repair is often associated with unsatisfactory outcomes and is associated with a high incidence of complications. This study aimed to evaluate the osteogenic effects of gelatin/β-tricalcium phosphate (GT) sponges loaded with different concentrations/ratios of mesenchymal stem cells (MSCs) and bone morphogenetic protein-2 (BMP-2) in an equine bone defect model. Seven thoroughbred horses were used in this study. Eight bone defects were created in the third metatarsal bones of each horse. Then, eight treatments, namely control, GT, GT/M-5, GT/M-6, GT/M-5/B-1, GT/M-5/B-3, GT/M-6/B-1, and GT/M-6/B-3 were applied to the eight different sites in a randomized manner (M-5: 2 × 105 MSCs; M-6: 2 × 106 MSCs; B-1: 1 μg of BMP-2; B-3: 3 μg of BMP-2). Repair of bone defects was assessed by radiography, quantitative computed tomography (QCT), and histopathological evaluation. Radiographic scores and CT values were significantly lower in the control group than in the other groups, while they were significantly higher in the GT/M-5/B-3 and GT/M-6/B-3 groups than in the other groups. The amount of mature compact bone filling the defects was greater in the GT/M-5/B-3 and GT/M-6/B-3 groups than in the other groups. The present study demonstrated that the GT sponge loaded with MSCs and BMP-2 promoted bone regeneration in an equine bone defect model. The GT/MSC/BMP-2 described here may be useful for treating horses with bone injuries.
Similar content being viewed by others
References
Bose S, Roy M, Bandyopadhyay A (2012) Recent advances in bone tissue engineering scaffolds. Trends Biotechnol 30:546–554
Cao H, Kuboyama N (2010) A biodegradable porous composite scaffold of PGA/beta-TCP for bone tissue engineering. Bone 46:386–395
Dégano IR, Vilalta M, Bagó JR, Matthies AM, Hubbell JA, Dimitriou H, Bianco P, Rubio N, Blanco J (2008) Bioluminescence imaging of calvarial bone repair using bone marrow and adipose tissue-derived mesenchymal stem cells. Biomaterials 29:427–437
Devescovi V, Leonardi E, Ciapetti G, Cenni E (2008) Growth factors in bone repair. Chir Organi Mov 92:161–168
Groeneveld EH, Burger EH (2000) Bone morphogenetic proteins in human bone regeneration. Eur J Endocrinol 142:9–21
Jang BJ, Byeon YE, Lim JH, Ryu HH, Kim WH, Koyama Y, Kikuchi M, Kang KS, Kweon OK (2008) Implantation of canine umbilical cord blood-derived mesenchymal stem cells mixed with beta-tricalcium phosphate enhances osteogenesis in bone defect model dogs. J Vet Sci 9:387–393
Johnson BJ, Stover SM, Daft BM, Kinde H, Read DH, Barr BC, Anderson M, Moore J, Woods L, Stoltz J (1994) Causes of death in racehorses over a 2 year period. Equine Vet J 26:327–330
Jones E, Yang X (2011) Mesenchymal stem cells and bone regeneration: current status. Injury 42:562–568
Khojasteh A, Behnia H, Hosseini FS, Dehghan MM, Abbasnia P, Abbas FM (2013) The effect of PCL-TCP scaffold loaded with mesenchymal stem cells on vertical bone augmentation in dog mandible: a preliminary report. J Biomed Mater Res B Appl Biomater 101:848–854
Kim J, Kim IS, Cho TH, Kim HC, Yoon SJ, Choi J, Park Y, Sun K, Hwang SJ (2010) In vivo evaluation of MMP sensitive high-molecular weight HA-based hydrogels for bone tissue engineering. J Biomed Mater Res A 95:673–681
Kim J, Kim IS, Cho TH, Lee KB, Hwang SJ, Tae G, Noh I, Lee SH, Park Y, Sun K (2007) Bone regeneration using hyaluronic acid-based hydrogel with bone morphogenic protein-2 and human mesenchymal stem cells. Biomaterials 28:1830–1837
Koch TG, Berg LC, Betts DH (2009) Current and future regenerative medicine - principles, concepts, and therapeutic use of stem cell therapy and tissue engineering in equine medicine. Can Vet J 50:155–165
Kon E, Muraglia A, Corsi A, Bianco P, Marcacci M, Martin I, Boyde A, Ruspantini I, Chistolini P, Rocca M, Giardino R, Cancedda R, Quarto R (2000) Autologous bone marrow stromal cells loaded onto porous hydroxyapatite ceramic accelerate bone repair in critical-size defects of sheep long bones. J Biomed Mater Res 49:328–337
Linde A, Hedner E (1995) Recombinant bone morphogenetic protein-2 enhances bone healing, guided by osteopromotive e-PTFE membranes: an experimental study in rats. Calcif Tissue Int 56:549–553
Lopez MJ, Markel MD (2012) Bone biology and fracture healing. In: Auer JA, Stick JA (eds) Equine surgery, 4th edn. Saunders, Philadelphia, pp 1025–1040
McDuffee LA, Pack L, Lores M, Wright GM, Esparza-Gonzalez B, Masaoud E (2012) Osteoprogenitor cell therapy in an equine fracture model. Vet Surg 41:773–783
Nöth U, Rackwitz L, Steinert AF, Tuan RS (2010) Cell delivery therapeutics for musculoskeletal regeneration. Adv Drug Deliv Rev 62:765–783
Perrier M, Lu Y, Nemke B, Kobayashi H, Peterson A, Markel M (2008) Acceleration of second and fourth metatarsal fracture healing with recombinant human bone morphogenetic protein-2/calcium phosphate cement in horses. Vet Surg 37:648–655
Schmökel HG, Weber FE, Seiler G, von Rechenberg B, Schense JC, Schawalder P, Hubbell J (2004) Treatment of nonunions with nonglycosylated recombinant human bone morphogenetic protein-2 delivered from a fibrin matrix. Vet Surg 33:112–118
Seo JP, Tsuzuki N, Haneda S, Yamada K, Furuoka H, Tabata Y, Sasaki N (2012) Proliferation of equine bone marrow-derived mesenchymal stem cells in gelatin/β-tricalcium phosphate sponges. Res Vet Sci 93:1481–1486
Tadokoro M, Matsushima A, Kotobuki N, Hirose M, Kimura Y, Tabata Y, Hattori K, Ohgushi H (2011) Bone morphogenetic protein-2 in biodegradable gelatin and β-tricalcium phosphate sponges enhances the in vivo bone-forming capability of bone marrow mesenchymal stem cells. J Tissue Eng Regen Med 6:253–260
Takahashi Y, Yamamoto M, Tabata Y (2005a) Enhanced osteoinduction by controlled release of bone morphogenetic protein-2 from biodegradable sponge composed of gelatin and beta-tricalcium phosphate. Biomaterials 26:4856–4865
Takahashi Y, Yamamoto M, Tabata Y (2005b) Osteogenic differentiation of mesenchymal stem cells in biodegradable sponges composed of gelatin and beta-tricalcium phosphate. Biomaterials 26:3587–3596
Terella A, Mariner P, Brown N, Anseth K, Streubel SO (2010) Repair of a calvarial defect with biofactor and stem cell-embedded polyethylene glycol scaffold. Arch Facial Plast Surg 12:166–171
Tsuzuki N, Otsuka K, Seo J, Yamada K, Haneda S, Furuoka H, Tabata Y, Sasaki N (2011) In vivo osteoinductivity of gelatin β-tri-calcium phosphate sponge and bone morphogenetic protein-2 on an equine third metacarpal bone defect. Res Vet Sci 93:1021–1025
Vo TN, Kasper FK, Mikos AG (2012) Strategies for controlled delivery of growth factors and cells for bone regeneration. Adv Drug Deliv Rev 64:1292–1309
Wang L, Huang Y, Pan K, Jiang X, Liu C (2010) Osteogenic responses to different concentrations/ratios of BMP-2 and bFGF in bone formation. Ann Biomed Eng 38:77–87
Yamaji K, Kawanami M, Matsumoto A, Odajima T, Nishitani Y, Iwasaka K, Yoshimitsu K, Yoshiyama M (2007) Effects of dose of recombinant human BMP-2 on bone formation at palatal sites in young and old rats. Dent Mater J 26:481–486
Yamamoto M, Ikada Y, Tabata Y (2001) Controlled release of growth factors based on biodegradation of gelatin hydrogel. J Biomater Sci Polym Ed 12:77–88
Zimmermann CE, Gierloff M, Hedderich J, Açil Y, Wiltfang J, Terheyden H (2011) Survival of transplanted rat bone marrow-derived osteogenic stem cells in vivo. Tissue Eng A 17:1147–1156
Acknowledgments
The authors thank Takashi Yamaga, Takafumi Tanabe, Hiroki Uchiyama, and Yoshinori Kambayashi for their assistance in bone marrow aspiration and postoperative care.
Conflict of interest
The authors declare no financial or personal conflicts of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Seo, Jp., Tsuzuki, N., Haneda, S. et al. Osteoinductivity of gelatin/β-tricalcium phosphate sponges loaded with different concentrations of mesenchymal stem cells and bone morphogenetic protein-2 in an equine bone defect model. Vet Res Commun 38, 73–80 (2014). https://doi.org/10.1007/s11259-013-9587-5
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11259-013-9587-5